Sequella CEO Carol Nacy On Partnering With Pfizer To Solve Multidrug-resistant TB
This article was originally published in PharmAsia News
Executive Summary
New drugs in development could help solve a looming global multidrug-resistant TB epidemic and anchor a new treatment regimen.